These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 6146687)

  • 1. Auranofin versus injectable gold. Comparison of pharmacokinetic properties.
    Blocka K
    Am J Med; 1983 Dec; 75(6A):114-22. PubMed ID: 6419592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Auranofin (Ridaura). A peroral gold salt].
    Manthorpe R
    Ugeskr Laeger; 1985 Mar; 147(10):888-90. PubMed ID: 3920800
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of auranofin in animals.
    Intoccia AP; Flanagan TL; Walz DT; Gutzait L; Swagzdis JE; Flagiello J; Hwang BY; Dewey RH; Noguchi H
    J Rheumatol Suppl; 1982; 8():90-8. PubMed ID: 6813497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triethylphosphine gold: cellular uptake and disposition after single and repeated oral doses in rats.
    Sharma RP; Smillie J; Laverty R
    J Pharm Pharmacol; 1984 Jul; 36(7):441-5. PubMed ID: 6146687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the kinetics of parenteral and oral gold.
    Gottlieb NL
    Scand J Rheumatol Suppl; 1983; 51():10-4. PubMed ID: 6426043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of oral and injectable gold compounds.
    Blocka KL; Paulus HE; Furst DE
    Clin Pharmacokinet; 1986; 11(2):133-43. PubMed ID: 3082559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacological profile of auranofin, an orally active gold compound.
    Walz DT; DiMartino MJ; Griswold DE
    Scand J Rheumatol Suppl; 1983; 51():16-25. PubMed ID: 6426049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic actions and pharmacokinetic studies of auranofin.
    Walz DT; DiMartino MJ; Griswold DE; Intoccia AP; Flanagan TL
    Am J Med; 1983 Dec; 75(6A):90-108. PubMed ID: 6318557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
    Batlle Gualda E
    Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
    [No Abstract]   [Full Text] [Related]  

  • 10. Review of auranofin, an oral chrysotherapeutic agent.
    Delafuente JC; Osborn TG
    Clin Pharm; 1984; 3(2):121-7. PubMed ID: 6426843
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.